A Novel Anti-LILRB4 CAR-T Cell for the Treatment of Monocytic AML

Written By Lara Wilson

John S. et al. 2018. Molecular Therapy 26(10):2487-2495.

Lara Wilson
Previous

LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration
Next

Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors